Influence of bisphosphonates on alveolar bone loss around osseointegrated implants

Journal of Oral Implantology

Volumn 37, Issue 3, 2011, Pages 335-346

  Zahid, Talal M ^a   Wang, Bing Yan ^a   Cohen, Robert E ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Alveolar bone loss; Bisphosphonates; Dental implants

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ADOLESCENT; ADULT; AGED; ALVEOLAR BONE LOSS; ARTICLE; CHEMICALLY INDUCED DISORDER; DENTAL SURGERY; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; STATISTICAL MODEL; TOOTH IMPLANTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALVEOLAR BONE LOSS; BONE DENSITY CONSERVATION AGENTS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; DIPHOSPHONATES; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 79958792565     PISSN: 01606972     EISSN: 15481336     Source Type: Journal    
DOI: 10.1563/AAID-JOI-D-09-00114     Document Type: Article

References (95)

1. Adell R, Lekholm U, Rockler B, Branemark PI. A 15-year study of osseointegrated implants in the treatment of the edentulous jaw. Int J Oral Surg. 1981;10:387-416. (Pubitemid 12014507)
2. Albrektsson T, Dahl E, Enbom L, et al. Osseointegrated oral implants. A Swedish multicenter study of 8139 consecutively inserted Nobelpharma implants. J Periodontol. 1988;59:287-296.
3. Branemark PI, Svensson B, van Steenberghe D. Ten-year survival rates of fixed prostheses on four or six implants ad modum Branemark in full edentulism. Clin Oral Implants Res. 1995;6:227-231.
4. Ekelund JA, Lindquist LW, Carlsson GE, Jemt T. Implant treatment in the edentulous mandible: a prospective study on Branemark system implants over more than 20 years. Int J Prosthodont. 2003;16:602-608. (Pubitemid 37526688)
5. Jemt T, Johansson J. Implant treatment in the edentulous maxillae: a 15-year follow-up study on 76 consecutive patients provided with fixed prostheses. Clin Implant Dent Relat Res. 2006;8:61-69. (Pubitemid 44154380)
6. Lindquist LW, Carlsson GE, Jemt T. A prospective 15-year follow-up study of mandibular fixed prostheses supported by osseointegrated implants. Clinical results and marginal bone loss. Clin Oral Implants Res. 1996;7: 329-336. (Pubitemid 126670549)
7. Jolly DE. Interpreting the clinical laboratory. J Calif Dent Assoc. 1995;23:32-40.
8. Piattelli A, Scarano A, Vaia E, Matarasso S. Histological evaluation of the peri-implant bone around plasma-sprayed non-submerged titanium implants retrieved from man: a report of two cases. Biomaterials. 1996;17:2219-2224. (Pubitemid 26390377)
9. Hwang D, Wang HL. Medical contraindications to implant therapy: part I: absolute contraindications. Implant Dent. 2006;15:353-360.
10. de Lange G, Tadjoedin E. Fate of the HA coating of loaded implants in the augmented sinus floor: a human case study of retrieved implants. Int J Periodontics Restorative Dent. 2002;22:287-296.
11. ADA Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc. 2006;137:1144-1150.
12. Nishimura RD, Roumanas E, Beumer J 3rd, Moy PK, Shimizu KT. Restoration of irradiated patients using osseointegrated implants: current perspectives. J Prosthet Dent. 1998;79:641-647.
13. Blomberg S. Psychological response. In: Branemark PI, Zarb GA, Albrektsson T, eds. Tissue-Integrated Prostheses: Osseointegration in Clinical Dentistry. 1st ed. Chicago, Ill: Quintessence; 1985:165-174.
14. Hwang D, Wang HL. Medical contraindications to implant therapy: Part II: relative contraindications. Implant Dent. 2007;16:13-23.
15. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement. 2000;17:1-45.
16. Dervis E. Oral implications of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100: 349-356. (Pubitemid 41191349)
17. Jeffcoat M. The association between osteoporosis and oral bone loss. J Periodontol. 2005;76:2125- 2132. (Pubitemid 41748962)
18. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther. 2007;29:1548-1558. (Pubitemid 47500128)
19. Albandar JM. Oral bisphosphonate therapy may not significantly compromise dental implants success. J Evid Based Dent Pract. 2008;8:229-231.
20. Grewal VS, Fayans EP. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management. Todays FDA. 2008;20:38-41.
21. Merigo E, Manfredi M, Meleti M, et al. Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases. Acta Biomed. 2006;77:109-117.
22. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate- associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer. 2005;104:83-93. (Pubitemid 40847755)
23. Kademani D, Koka S, Lacy MQ, Rajkumar SV. Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy. Mayo Clin Proc. 2006;81:1100-1103. (Pubitemid 44175022)
24. Purcell PM, Boyd IW. Bisphosphonates and osteonecrosis of the jaw. Med J Aust. 2005;182:417-418. (Pubitemid 40561699)
25. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62:527-534. (Pubitemid 38542516)
26. Nase JB, Suzuki JB. Osteonecrosis of the jaw and oral bisphosphonate treatment. J Am Dent Assoc. 2006;137:1115-1119; quiz 1169-1170. (Pubitemid 44367957)
27. Yeo AC, Lye KW, Poon CY. Bisphosphonaterelated osteonecrosis of the jaws. Singapore Dent J. 2005;27:36-40.
28. Farrugia MC, Summerlin DJ, Krowiak E, et al. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Laryngoscope. 2006;116:115-120. (Pubitemid 44383974)
29. Marunick M, Miller R, Gordon S. Adverse oral sequelae to bisphosphonate administration. J Mich Dent Assoc. 2005;87:44-49.
30. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005;63:1567-1575. (Pubitemid 41525412)
31. Cheng A, Mavrokokki A, Carter G, et al. The dental implications of bisphosphonates and bone disease. Aust Dent J. 2005;50(4 suppl 2):S4-13. (Pubitemid 43074661)
32. Payne JB, Reinhardt RA, Nummikoski PV, Dunning DG, Patil KD. The association of cigarette smoking with alveolar bone loss in postmenopausal females. J Clin Periodontol. 2000;27:658-664.
33. Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol. 2000;71:1492-1498.
34. Humphries S, Devlin H, Worthington H. A radiographic investigation into bone resorption of mandibular alveolar bone in elderly edentulous adults. J Dent. 1989;17:94-96.
35. Ortman LF, Hausmann E, Dunford RG. Skeletal osteopenia and residual ridge resorption. J Prosthet Dent. 1989;61:321-325.
36. Hirai T, Ishijima T, Hashikawa Y, Yajima T. Osteoporosis and reduction of residual ridge in edentulous patients. J Prosthet Dent. 1993;69:49-56.
37. Daniell HW. Postmenopausal tooth loss. Contributions to edentulism by osteoporosis and cigarette smoking. Arch Intern Med. 1983;143:1678-1682. (Pubitemid 13007143)
38. Kribbs PJ, Chesnut CH 3rd, Ott SM, Kilcoyne RF. Relationships between mandibular and skeletal bone in a population of normal women. J Prosthet Dent. 1990; 63:86-89.
39. Kribbs PJ, Chesnut CH 3rd, Ott SM, Kilcoyne RF. Relationships between mandibular and skeletal bone in an osteoporotic population. J Prosthet Dent. 1989;62: 703-707.
40. Astrom J, Backstrom C, Thidevall G. Tooth loss and hip fractures in the elderly. J Bone Joint Surg Br. 1990;72:324-325. (Pubitemid 20087455)
41. Krall EA, Dawson-Hughes B, Papas A, Garcia RI. Tooth loss and skeletal bone density in healthy postmenopausal women. Osteoporos Int. 1994;4:104- 109. (Pubitemid 24103704)
42. Taguchi A, Tanimoto K, Suei Y, Otani K, Wada T. Oral signs as indicators of possible osteoporosis in elderly women. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:612-616.
43. Taguchi A, Tanimoto K, Suei Y, Wada T. Tooth loss and mandibular osteopenia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:127-132.
44. Krall EA, Garcia RI, Dawson-Hughes B. Increased risk of tooth loss is related to bone loss at the whole body, hip, and spine. Calcif Tissue Int. 1996;59:433-437. (Pubitemid 26397161)
45. Krall EA, Dawson-Hughes B, Hannan MT, Wilson PW, Kiel DP. Postmenopausal estrogen replacement and tooth retention. Am J Med. 1997;102:536-542. (Pubitemid 27305116)
46. Bando K, Nitta H, Matsubara M, Ishikawa I. Bone mineral density in periodontally healthy and edentulous postmenopausal women. Ann Periodontol. 1998;3: 322-326.
47. Xie Q, Ainamo A. Association of edentulousness with systemic factors in elderly people living at home. Community Dent Oral Epidemiol. 1999;27:202-209.
48. Phillips HB, Ashley FP. The relationship between periodontal disease and a metacarpal bone index. Br Dent J. 1973;134:237-239.
49. Ward VJ, Manson JD. Alveolar bone loss in periodontal disease and the metacarpal index. J Periodontol. 1973;44:763-769.
50. Kribbs PJ. Comparison of mandibular bone in normal and osteoporotic women. J Prosthet Dent. 1990;63:218-222.
51. Alsaadi G, Quirynen M, Komarek A, van Steenberghe D. Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. J Clin Periodontol. 2007;34:610- 617.
52. Alsaadi G, Quirynen M, Michiles K, Teughels W, Komarek A, van Steenberghe D. Impact of local and systemic factors on the incidence of failures up to abutment connection with modified surface oral implants. J Clin Periodontol. 2008;35:51-57.
53. van Steenberghe D, Jacobs R, Desnyder M, Maffei G, Quirynen M. The relative impact of local and endogenous patient-related factors on implant failure up to the abutment stage. Clin Oral Implants Res. 2002;13:617-622. (Pubitemid 41749849)
54. Attard NJ, Zarb GA. A study of dental implants in medically treated hypothyroid patients. Clin Implant Dent Relat Res. 2002;4:220-231.
55. Casap N, Nimri S, Ziv E, Sela J, Samuni Y. Type 2 diabetes has minimal effect on osseointegration of titanium implants in Psammomys obesus. Clin Oral Implants Res. 2008;19:458-464.
56. el Askary AS, Meffert RM, Griffin T. Why do dental implants fail? Part II. Implant Dent. 1999;8:265- 277.
57. el Askary AS, Meffert RM, Griffin T. Why do dental implants fail? Part I. Implant Dent. 1999;8:173- 185.
58. Klokkevold PR, Han TJ. How do smoking, diabetes, and periodontitis affect outcomes of implant treatment? Int J Oral Maxillofac Implants. 2007;22 (suppl):173-202.
59. Lambert PM, Morris HF, Ochi S. The influence of smoking on 3-year clinical success of osseointegrated dental implants. Ann Periodontol. 2000;5:79-89.
60. Linkow LI, Rinaldi AW, Weiss WW Jr, Smith GH. Factors influencing long-term implant success. J Prosthet Dent. 1990;63:64-73.
61. Ong CT, Ivanovski S, Needleman IG, et al. Systematic review of implant outcomes in treated periodontitis subjects. J Clin Periodontol. 2008;35:438- 462.
62. Quirynen M, De Soete M, van Steenberghe D. Infectious risks for oral implants: a review of the literature. Clin Oral Implants Res. 2002;13:1-19. (Pubitemid 41719934)
63. Sverzut AT, Stabile GA, de Moraes M, Mazzonetto R, Moreira RW. The influence of tobacco on early dental implant failure. J Oral Maxillofac Surg. 2008;66: 1004-1009. (Pubitemid 351514845)
64. Weyant RJ, Burt BA. An assessment of survival rates and within-patient clustering of failures for endosseous oral implants. J Dent Res. 1993;72:2-8.
65. Becker W, Hujoel PP, Becker BE, Willingham H. Osteoporosis and implant failure: an exploratory casecontrol study. J Periodontol. 2000;71:625-631.
66. Smith RA, Berger R, Dodson TB. Risk factors associated with dental implants in healthy and medically compromised patients. Int J Oral Maxillofac Implants. 1992;7:367-372.
67. Dao TT, Anderson JD, Zarb GA. Is osteoporosis a risk factor for osseointegration of dental implants? Int J Oral Maxillofac Implants. 1993;8:137-144.
68. Friberg B. Treatment with dental implants in patients with severe osteoporosis: a case report. Int J Periodontics Restorative Dent. 1994;14:348-353.
69. Fujimoto T, Niimi A, Nakai H, Ueda M. Osseointegrated implants in a patient with osteoporosis: a case report. Int J Oral Maxillofac Implants. 1996;11: 539-542. (Pubitemid 126701396)
70. Eder A, Watzek G. Treatment of a patient with severe osteoporosis and chronic polyarthritis with fixed implant-supported prosthesis: a case report. Int J Oral Maxillofac Implants. 1999;14:587-590.
71. Minsk L, Polson AM. Dental implant outcomes in postmenopausal women undergoing hormone replacement. Compend Contin Educ Dent. 1998;19: 859-862, 864; quiz 866.
72. August M, Chung K, Chang Y, Glowacki J. Influence of estrogen status on endosseous implant osseointegration. J Oral Maxillofac Surg. 2001;59:1285- 1289. (Pubitemid 33021949)
73. Moy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants. 2005;20:569-577. (Pubitemid 41549224)
74. Degidi M, Piattelli A. Immediately loaded barconnected implants with an anodized surface inserted in the anterior mandible in a patient treated with diphosphonates for osteoporosis: a case report with a 12-month follow-up. Clin Implant Dent Relat Res. 2003;5: 269-272. (Pubitemid 38249677)
75. O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol. 1972;43:38.
76. Löe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol. 1967; 38(suppl):610-616.
77. Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efficacy of currently used dental implants: a review and proposed criteria of success. Int J Oral Maxillofac Implants. 1986;1:11-25.
78. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
79. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049-1060. (Pubitemid 19026037)
80. Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol. 2007;78:1664-1669.
81. Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg. 2008;66:223-230.
82. Bell BM, Bell RE. Oral bisphosphonates and dental implants: a retrospective study. J Oral Maxillofac Surg. 2008;66:1022-1024. (Pubitemid 351514838)
83. Jeffcoat MK. Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants. 2006;21:349-353. (Pubitemid 43962658)
84. Duarte PM, de Vasconcelos Gurgel BC, Sallum AW, Filho GR, Sallum EA, Nociti FH Jr. Alendronate therapy may be effective in the prevention of bone loss around titanium implants inserted in estrogen-deficient rats. J Periodontol. 2005;76:107-114. (Pubitemid 40439666)
85. Giro G, Goncalves D, Sakakura CE, Pereira RM, Marcantonio Junior E, Orrico SR. Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:162- 167.
86. Starck WJ, Epker BN. Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report. Int J Oral Maxillofac Implants. 1995;10:74-78.
87. Kasai T, Pogrel MA, Hossaini M. The prognosis for dental implants placed in patients taking oral bisphosphonates. J Calif Dent Assoc. 2009;37:39-42.
88. Torres J, Tamimi F, Garcia I, et al. Dental implants in a patient with Paget disease under bisphosphonate treatment: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:387- 392.
89. Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report. J Periodontol. 2007;78:584-594.
90. Branemark PI, Zarb G, Albrektsson T. Tissue- Integrated Prostheses: Osseointegration in Clinical Dentistry. Chicago, Ill: Quintessence; 1985:233-240.
91. Hughes DE, MacDonald BR, Russell RG, Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest. 1989;83:1930-1935. (Pubitemid 19148862)
92. Hughes DE, Wright KR, Uy HL, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res. 1995;10:1478-1487.
93. Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF. A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res. 1996;11:150-159. (Pubitemid 26054173)
94. Fournier P, Boissier S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone- stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res. 2002;62:6538- 6544. (Pubitemid 35364119)
95. Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 2000;15:613-620. (Pubitemid 30174014)